Mark R. Brunswick, Ph.D.
« Rov qab mus rau Pab Pawg
Senior Vice President Regulatory Affairs
- Dr. Brunswick muaj ntau tshaj 35 xyoo ntawm cov haujlwm laus hauv Kev Tswj Xyuas Kev Lag Luam suav nrog ntau dua 9 xyoo hauv US FDA, Center for Biologics, Division of Monoclonal Antibodies
- Ua ntej koom nrog Sorrento, Dr. Brunswick yog Tus Thawj Saib Xyuas Kev Tswj Xyuas Kev Tswj Xyuas thiab Kev Ua Haujlwm Zoo ntawm Sophiris Bio, lub tuam txhab tsim tshuaj rau benign prostatic hyperplasia thiab mob qog noj ntshav prostate. Ua ntej nws yog tus thawj coj ntawm Kev Tswj Xyuas Kev Ua Haujlwm ntawm Arena Pharmaceuticals tshwj xeeb hauv kev kho mob qhia ntawm G Protein receptors
- Dr. Brunswick coj pawg tswj hwm ntawm Elan Pharmaceuticals tsom rau Alzheimer Disease thiab mob compound, ziconotide
- BS thiab Ph.D.